Article
PIK3CA mutations rarely demonstrate genotypic intratumoral heterogeneity and are selected for in breast cancer progression.
Breast cancer research and treatment - 1 Sept 2011
Kalinsky Kevin, Heguy Adriana, Bhanot Umeshkumar K, Patil Sujata, Moynahan Mary Ellen
Abstract excerpt
PIK3CA gene mutations are the most common activating mutations in human breast cancer. Its association with hormone receptor-positive breast cancer makes it a prime target for clinical therapeutic advances to maintain anti-estrogen responsiveness. In anticipation of this therapeutic approach, we have evaluated intratumoral heterogeneity in primary breast cancers with regard to PIK3CA mutation status. In addition,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
